Active Ingredient History

NOW
  • Now
Eltoprazine is a serotonergic drug of the phenylpiperazine class which is described as a serenic or antiaggressive agent. It acts as an agonist of the serotonin 5-HT1A and 5-HT1B receptors and as an antagonist of the serotonin 5-HT2C receptor. The drug is closely related to fluprazine and batoprazine, which are similarly acting agents, and is also a known chemical precursor to S-15535 and lecozotan. Eltoprazine is or was under development for the treatment of aggression, attention deficit hyperactivity disorder (ADHD), cognition disorders, and drug-induced dyskinesia, but no recent development has been reported for these indications as of February 2022. It was also under development for the treatment of psychotic disorders, but development for this indication was discontinued. Eltoprazine was originated by Solvay and was developed by Elto Pharma, PsychoGenics, and Solvay.   Wikipedia

  • SMILES: C1CN(CCN1)c2cccc3OCCOc23
  • InChIKey: WVLHGCRWEHCIOT-UHFFFAOYSA-N
  • Mol. Mass: 220.27
  • ALogP: 0.87
  • ChEMBL Molecule:
More Chemistry
1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine | du 28853 | du-28853 | eltoprazine | eltoprazine hydrochloride

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue